FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

F M E Wagenlehner

Research Profile

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
F M E Wagenlehner; Wolfgang Weidner; Jos G A Houbiers; Vittorio Magri; Gianpaolo Perletti; J W Olivier van Till; J Curtis Nickel
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.
W Vahlensieck; F M E Wagenlehner; M Ludwig; K Naber; W Fabry
[Prostatitis - diagnostics and therapy].
F M E Wagenlehner; Wolfgang Weidner; H W Bauer; H J Piechota; W Vahlensieck; Kurt G Naber
Prevention of recurrent urinary tract infections.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of F M E Wagenlehner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: F M E Wagenlehner; Wolfgang Weidner; Jos G A Houbiers; Vittorio Magri; Gianpaolo Perletti; J W Olivier van Till; J Curtis Nickel
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.
European urology 2013;63(5):953-9.
2013: W Vahlensieck; F M E Wagenlehner; M Ludwig; K Naber; W Fabry
[Prostatitis - diagnostics and therapy].
Aktuelle Urologie 2013;44(2):117-23.
2013: F M E Wagenlehner; Wolfgang Weidner; H W Bauer; H J Piechota; W Vahlensieck; Kurt G Naber
Prevention of recurrent urinary tract infections.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2013;65(1):9-20.
2013: Adrian Pilatz; H Renz; Hans-Christian Schuppe; F M E Wagenlehner; Wolfgang Weidner; Thorsten Diemer; C Hudemann; Thomas Bschleipfer
[Seminal cytokines: is quantification useful in urogenital disorders?].
Der Urologe. Ausg. A 2013;52(3):359-66.
2013: F M E Wagenlehner; Wolfgang Weidner; Björn Wullt; Mete Cek; Truls E Bjerklund Johansen; Magnus Grabe; Kurt G Naber; Robert Pickard; Adrian Pilatz; Zafer Tandogdu; Peter Tenke; Edgar van Oostrum
Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.
European urology 2013;63(3):521-7.
2012: Adrian Pilatz; F M E Wagenlehner; M Bürger; G Lüdecke; Wolfgang Weidner
Clinical evaluation of human epididymis protein 4 as a biomarker for epididymitis.
Biomarkers in medicine 2012;6(3):311-7.
2012: R Fünfstück; T Olschläger; F M E Wagenlehner; K G Naber
[Urinary tract infections: cystitis, pyelonephritis, urosepsis].
Deutsche medizinische Wochenschrift (1946) 2012;137(5):198-201.
2012: F M E Wagenlehner; Mete Cek; Hiroshi Kiyota; Kurt G Naber; Truls E Bjerklund Johansen
Epidemiology, treatment and prevention of healthcare-associated urinary tract infections.
World journal of urology 2012;30(1):59-67.
2012: F M E Wagenlehner; Tetsuro Matsumoto
Infections in urology.
World journal of urology 2012;30(1):1-2.
2012: Magnus Grabe; Kurt G Naber; Peter Tenke; F M E Wagenlehner; Henry Botto; Mete Cek; Truls E Bjerklund Johansen
Preoperative assessment of the patient and risk factors for infectious complications and tentative classification of surgical field contamination of urological procedures.
World journal of urology 2012;30(1):39-50.
2012: A Rusz; Hans-Christian Schuppe; F M E Wagenlehner; Thorsten Diemer; Hamid Hossain; T Linn; Jürgen Lohmeyer; Adrian Pilatz; Wolfgang Weidner
Influence of urogenital infections and inflammation on semen quality and male fertility.
World journal of urology 2012;30(1):23-30.
2012: Peter Tenke; F M E Wagenlehner; Björn Wullt; Henry Botto; Mete Cek; Magnus Grabe; Scott J Hultgren; Béla Köves; Werner Mendling; Kurt G Naber; Károly Nagy; Robert Pickard; Truls E Bjerklund Johansen
Update on biofilm infections in the urinary tract.
World journal of urology 2012;30(1):51-7.
2011: F M E Wagenlehner; T E Bjerklund Johansen; M Grabe; C K Naber; Kurt G Naber; Wolfgang Weidner
[Antibiotic prophylaxis in urology].
Der Urologe. Ausg. A 2011;50(11):1469-78; quiz 1479-80.
2011: Gianpaolo Perletti; V Skerk; F M E Wagenlehner; Michael John Parnham; Vittorio Magri; A Markotic; S Mazzoli; K G Naber
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review).
Molecular medicine reports 2011;4(6):1035-44.
2011: F M E Wagenlehner; Wolfgang Weidner; H W Bauer; Kurt G Naber; W Vahlensieck; H J Piechota
[Primary and secondary prevention of urinary tract infections].
Der Urologe. Ausg. A 2011;50(10):1248, 1250-2, 1254-6.
2011: F M E Wagenlehner; Thomas Bschleipfer; Adrian Pilatz; Wolfgang Weidner
Pollen extract for chronic prostatitis-chronic pelvic pain syndrome.
The Urologic clinics of North America 2011;38(3):285-92.
2011: F M E Wagenlehner; K Roscher; Kurt G Naber
[Practice management of chronic bacterial prostatitis with levofloxacin].
Aktuelle Urologie 2011;42(3):184-9.
2011: T Bschleipfer; F M E Wagenlehner; Wolfgang Weidner
[Etiology and pathogenesis of overactive bladder].
Der Urologe. Ausg. A 2011;50(4):477-80.
2011: F M E Wagenlehner; Thomas Bschleipfer; Wolfgang Weidner; B Liedl; A Gunnemann
A comprehensive anatomical view on pelvic floor disturbances.
Neurourology and urodynamics 2011;30(3):366-7.
2011: F M E Wagenlehner; G Schmiemann; U Hoyme; R Fünfstück; E Hummers-Pradier; M Kaase; E Kniehl; I Selbach; U Sester; W Vahlensieck; D Watermann; Kurt G Naber
[National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
Der Urologe. Ausg. A 2011;50(2):153-69.
2011: F M E Wagenlehner; W Vahlensieck; K G Naber
[New S3 guidelines "uncomplicated urinary tract infections"].
Der Urologe. Ausg. A 2011;50(2):151-2.
2011: Jürgen Bulitta; Martina Kinzig; Cornelia Landersdorfer; Christoph K Naber; Christian Sauber; Fritz Sörgel; F M E Wagenlehner; Kurt G Naber
Population pharmacokinetics and penetration into prostatic, seminal, and vaginal fluid for ciprofloxacin, levofloxacin, and their combination.
Chemotherapy 2011;57(5):402-16.
2011: F M E Wagenlehner; Christine M Wagenlehner; Birgit Blenk; Holger Blenk; Sabine Schubert; Axel Dalhoff; Kurt G Naber
Urinary pharmacokinetics and bactericidal activity of finafloxacin (200 and 800 mg) in healthy volunteers receiving a single oral dose.
Chemotherapy 2011;57(2):97-107.
2011: F M E Wagenlehner; W Vahlensieck; D Watermann; Wolfgang Weidner; Kurt G Naber
[Uncomplicated urinary tract infection and treatment].
Aktuelle Urologie 2011;42(1):33-7.
2011: F M E Wagenlehner; Knut Bescherer; Christine Wagenlehner; Michael Zellner; Wolfgang Weidner; Kurt G Naber
Urodynamic impact of acute urinary retention in patients with benign prostatic hyperplasia: a 2-year follow-up after transurethral resection of the prostate.
Urologia internationalis 2011;86(1):73-9.
2010: Thorsten Diemer; F M E Wagenlehner
[Selection of scientific contributions to the DGU Congress 2010.].
Der Urologe. Ausg. A 2010;49 Suppl 1():6-8.
2010: F M E Wagenlehner; Wolfgang Weidner; Gianpaolo Perletti; Kurt G Naber
Emerging drugs for bacterial urinary tract infections.
Expert opinion on emerging drugs 2010;15(3):375-97.
2010: F M E Wagenlehner; C Lichtenstern; M A Weigand; Wolfgang Weidner
[Urosepsis and treatment].
Der Urologe. Ausg. A 2010;49(5):618-22.
2010: F M E Wagenlehner; Wolfgang Weidner
[Urogenital infections and their sequelae].
Der Urologe. Ausg. A 2010;49(5):597.
2010: F M E Wagenlehner; C Wagenlehner; O Savov; L Gualco; G Schito; Kurt G Naber
[Clinical aspects and epidemiology of uncomplicated cystitis in women. German results of the ARESC Study].
Der Urologe. Ausg. A 2010;49(2):253-61.
2010: F M E Wagenlehner; Thomas Bschleipfer; B Liedl; A Gunnemann; P Petros; Wolfgang Weidner
Surgical reconstruction of pelvic floor descent: anatomic and functional aspects.
Urologia internationalis 2010;84(1):1-9.
2009: F M E Wagenlehner
Editorial comment on: Comparative assessment of antimicrobial activities of antibiotic-treated penile prostheses.
European urology 2009;56(6):1045-6.
2009: F M E Wagenlehner; A Gunnemann; B Liedl; Wolfgang Weidner
[Functional aspects of pelvic floor surgery].
Aktuelle Urologie 2009;40(6):345-50.
2009: Marcelo Marconi; Adrian Pilatz; F M E Wagenlehner; Thorsten Diemer; Wolfgang Weidner
Are antisperm antibodies really associated with proven chronic inflammatory and infectious diseases of the male reproductive tract?
European urology 2009;56(4):708-15.
2009: F M E Wagenlehner; Henning Schneider; Martin Ludwig; Jörg Schnitker; Elmar Braehler; Wolfgang Weidner
A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
European urology 2009;56(3):544-51.
2009: Agnieszka Paradowska; Irina Fenic; Lutz Konrad; Klaus Sturm; F M E Wagenlehner; Wolfgang Weidner; Klaus Steger
Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
International journal of oncology 2009;35(1):87-96.
2009: F M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
An update on uncomplicated urinary tract infections in women.
Current opinion in urology 2009;19(4):368-74.
2009: M Marconi; Adrian Pilatz; F M E Wagenlehner; Thorsten Diemer; Wolfgang Weidner
Impact of infection on the secretory capacity of the male accessory glands.
International braz j urol : official journal of the Brazilian Society of Urology 2009;35(3):299-308; discussion 308-9.
2009: F M E Wagenlehner; Christine Wagenlehner; Rebecca Redman; Wolfgang Weidner; Kurt G Naber
Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis.
Antimicrobial agents and chemotherapy 2009;53(4):1567-73.
2009: Gianpaolo Perletti; F M E Wagenlehner; K G Naber; V Magri
Enhanced distribution of fourth-generation fluoroquinolones in prostatic tissue.
International journal of antimicrobial agents 2009;33(3):206-10.
2008: F M E Wagenlehner; Adrian Pilatz; Kurt G Naber; Wolfgang Weidner
Therapeutic challenges of urosepsis.
European journal of clinical investigation 2008;38 Suppl 2():45-9.
2008: Wolfgang Weidner; F M E Wagenlehner; M Marconi; Adrian Pilatz; K H P Pantke; Thorsten Diemer
Acute bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: andrological implications.
Andrologia 2008;40(2):105-12.
2008: F M E Wagenlehner; Thorsten Diemer; Kurt G Naber; Wolfgang Weidner
Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status.
Andrologia 2008;40(2):100-4.
2008: F M E Wagenlehner; W Weidner; K G Naber
Antibiotics in urology: new essentials.
The Urologic clinics of North America 2008;35(1):69-79; vi.
2008: F M E Wagenlehner; A H Niemetz; W Weidner; Kurt G Naber
Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005.
International journal of antimicrobial agents 2008;31 Suppl 1():S25-34.
2008: F M E Wagenlehner; Adrian Pilatz; K G Naber; G Perletti; C M Wagenlehner; Wolfgang Weidner
Anti-infective treatment of bacterial urinary tract infections.
Current medicinal chemistry 2008;15(14):1412-27.
2008: F M E Wagenlehner; F Kees; Wolfgang Weidner; Christine Wagenlehner; Kurt G Naber
Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers.
International journal of antimicrobial agents 2008;31(1):21-6.
2007: F M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Optimal management of urosepsis from the urological perspective.
International journal of antimicrobial agents 2007;30(5):390-7.
2007: F M E Wagenlehner; Kurt G Naber; E Bambl; Ulla Raab; Christine Wagenlehner; Dagmar Kahlau; C Höller; Wolfgang Witte; Wolfgang Weidner; N Lehn; Stephan Harbarth; H-J Linde
Management of a large healthcare-associated outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in Germany.
The Journal of hospital infection 2007;67(2):114-20.
2007: F M E Wagenlehner; Johny E Elkahwaji; Ferran Algaba; Truls E Bjerklund Johansen; Kurt G Naber; Rudolf Hartung; Wolfgang Weidner
The role of inflammation and infection in the pathogenesis of prostate carcinoma.
BJU international 2007;100(4):733-7.
2007: Thomas Bschleipfer; F M E Wagenlehner; Wolfgang Weidner
[Intraprostatic botulinum toxin A injection in chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS)].
Der Urologe. Ausg. A 2007;46(9):1030-2.
2007: Thomas Bschleipfer; F M E Wagenlehner; Wolfgang Weidner
[Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].
Der Urologe. Ausg. A 2007;46(9):1027-30.
2007: F M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Therapy for prostatitis, with emphasis on bacterial prostatitis.
Expert opinion on pharmacotherapy 2007;8(11):1667-74.
2007: F M E Wagenlehner; H Schneider; Wolfgang Weidner
[Prostatitis syndrome].
Der Urologe. Ausg. A 2007;46(2):W185-96; quiz W197.
2007: F M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis.
Clinical pharmacokinetics 2007;46(4):291-305.
2006: Wolfgang Weidner; F M E Wagenlehner; Thorsten Diemer
[Chlamydia infections of the male: what is relevant for urologists?].
Der Urologe. Ausg. A 2006;45(12):1504-8.
2006: F M E Wagenlehner; Martina Kinzig; Fritz Sörgel; W Weidner; Kurt G Naber
Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
International journal of antimicrobial agents 2006;28(6):551-9.
2006: F M E Wagenlehner; Martina Kinzig; Uwe Tischmeyer; Christine Wagenlehner; Fritz Sörgel; Kurt G Naber
Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Antimicrobial agents and chemotherapy 2006;50(11):3947-9.
2006: F M E Wagenlehner; J C Lunz; F Kees; Wolf F Wieland; KG Naber
Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
Journal of chemotherapy (Florence, Italy) 2006;18(5):485-9.
2006: Wolfgang Weidner; Kurt G Naber; A G Hofstetter; Martin Ludwig; W Vahlensieck; F M E Wagenlehner; P Schneede
[Infections of the urinary tract and male genitalia].
Der Urologe. Ausg. A 2006;45 Suppl 4():145-9.
2006: F M E Wagenlehner; E Loibl; H Vogel; Kurt G Naber
Incidence of nosocomial urinary tract infections on a surgical intensive care unit and implications for management.
International journal of antimicrobial agents 2006;28 Suppl 1():S86-90.
2006: F M E Wagenlehner; Kurt G Naber
Current challenges in the treatment of complicated urinary tract infections and prostatitis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006;12 Suppl 3():67-80.
2006: F M E Wagenlehner; Kurt G Naber; Wolfgang Weidner
Chlamydial infections and prostatitis in men.
BJU international 2006;97(4):687-90.
2006: F M E Wagenlehner; U Hoyme; Kurt Naber
[Therapy of the acute uncomplicated urinary tract infection].
Der Urologe. Ausg. A 2006;45(4):429-32, 434-5.
2006: F M E Wagenlehner; U Sester; Kurt Naber
[Guidelines for management of urinary tract infections in adults--an initiative].
Der Urologe. Ausg. A 2006;45(4):464-6.
2006: F M E Wagenlehner; Giorgina Barbara Piccoli; Kurt G Naber
Uraemia, psychosis, young patient: an uncommon link. Urinary tract and miliary tuberculosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(4):1113-6.
2006: Ulla Raab; Dagmar Kahlau; F M E Wagenlehner; Udo Reischl; Vera Ehrenstein; Norbert Lehn; Christiane Holler; Hans-Jorg Linde
Prevalence of and risk factors for carriage of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus among residents and staff of a German nursing home.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(2):208-11.
2006: F M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Chlamydial infections in urology.
World journal of urology 2006;24(1):4-12.
2006: F M E Wagenlehner; Kurt G Naber
Treatment of bacterial urinary tract infections: presence and future.
European urology 2006;49(2):235-44.
2006: F M E Wagenlehner; Martina Kinzig; Uwe Tischmeyer; Christine Wagenlehner; Fritz Sörgel; Axel Dalhoff; Kurt G Naber
Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
International journal of antimicrobial agents 2006;27(1):7-14.
2005: F M E Wagenlehner; W Weidner; Fritz Sörgel; K G Naber
The role of antibiotics in chronic bacterial prostatitis.
International journal of antimicrobial agents 2005;26(1):1-7.
2005: F M E Wagenlehner; W Weidner; K G Naber
Emergence of antibiotic resistance amongst hospital-acquired urinary tract infections and pharmacokinetic/pharmacodynamic considerations.
The Journal of hospital infection 2005;60(3):191-200.
2005: Hans-Jorg Linde; F M E Wagenlehner; B Strommenger; I Drubel; J Tanzer; Udo Reischl; Ulla Raab; C Höller; K G Naber; Wolfgang Witte; Frank Hanses; Bernd Salzberger; Norbert Lehn
Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2005;24(6):419-22.
2005: F M E Wagenlehner; Wolfgang Weidner; Kurt G Naber
Emerging drugs for bacterial urinary tract infections.
Expert opinion on emerging drugs 2005;10(2):275-98.
2005: F M E Wagenlehner; Norbert Lehn; Wolfgang Witte; Kurt G Naber
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
Chemotherapy 2005;51(2-3):64-9.
2005: F M E Wagenlehner; Christine Wagenlehner; S Schinzel; Kurt G Naber
Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.
European urology 2005;47(4):549-56.
2005: F M E Wagenlehner; Kurt G Naber; Wolfgang Weidner
Asymptomatic bacteriuria in elderly patients: significance and implications for treatment.
Drugs & aging 2005;22(10):801-7.
2004: F M E Wagenlehner; Kurt G Naber
Antibiotic treatment for urinary tract infections: pharmacokinetic/pharmacodynamic principles.
Expert review of anti-infective therapy 2004;2(6):923-31.
2004: F M E Wagenlehner; Kurt G Naber
New drugs for Gram-positive uropathogens.
International journal of antimicrobial agents 2004;24 Suppl 1():S39-43.
2004: F M E Wagenlehner; K G Naber
Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men.
Current urology reports 2004;5(4):309-16.
2004: F M E Wagenlehner; Kurt G Naber
Emergence of antibiotic resistance and prudent use of antibiotic therapy in nosocomially acquired urinary tract infections.
International journal of antimicrobial agents 2004;23 Suppl 1():S24-9.
2003: F M E Wagenlehner; Stephan Wydra; Hajime Onda; Martina Kinzig; Fritz Sörgel; Kurt G Naber
Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Antimicrobial agents and chemotherapy 2003;47(12):3789-94.
2003: F M E Wagenlehner; Kurt Naber
[Recurrent urinary tract infections should not be treated cavalierly. First verify the diagnosis!].
MMW Fortschritte der Medizin 2003;145(43):37-9.
2003: F M E Wagenlehner; Peter Heisig; C Irtenkauf; Frank Notka; Jochen Decker; Norbert Lehn; Hans-Jörg Linde
Clinically significant borderline resistance of sequential clinical isolates of Klebsiella pneumoniae.
International journal of antimicrobial agents 2003;22(4):367-73.
2003: F M E Wagenlehner; K G Naber
Antimicrobial treatment of prostatitis.
Expert review of anti-infective therapy 2003;1(2):275-82.
2003: F M E Wagenlehner; B Mohren; K G Naber; H F K Männl
Abdominal actinomycosis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(8):881-5.
2003: F M E Wagenlehner; K G Naber
Prostatitis: the role of antibiotic treatment.
World journal of urology 2003;21(2):105-8.
2003: P E Sterr; F M E Wagenlehner; K G Naber
[Traumatic renal pelvis rupture associated with previously unknown stenosis at the renal pelvis junction].
Aktuelle Urologie 2003;34(2):119-20.
2003: F M E Wagenlehner
[How should chronic recurrent cystitis be treated?].
Deutsche medizinische Wochenschrift (1946) 2003;128(4):158.
2002: F M E Wagenlehner; Fiona M MacKenzie; KJ Forbes; Ian M Gould
Molecular epidemiology and antibiotic resistance of Enterobacter spp. from three distinct populations in Grampian, UK.
International journal of antimicrobial agents 2002;20(6):419-25.
2002: F M E Wagenlehner; K G Naber
[Bacterial urinary tract infections--what is only an annoyance, when is risk involved?].
Therapeutische Umschau. Revue thérapeutique 2002;59(9):464-8.
2002: Wolfgang Weidner; Werner W Hochreiter; B Liedl; Martin Ludwig; Kurt G Naber; W Vahlensiek; F M E Wagenlehner
[Urogenital infections in the elderly].
Der Urologe. Ausg. A 2002;41(4):328-32.
2002: F M E Wagenlehner; S Krcmery; C Held; Ingo Klare; Wolfgang Witte; Adolf Bauernfeind; I Schneider; K G Naber
Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parameters.
International journal of antimicrobial agents 2002;19(6):583-91.
2002: F M E Wagenlehner; A Niemetz; A Dalhoff; Kurt G Naber
Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994-2000.
International journal of antimicrobial agents 2002;19(6):557-64.
2001: Kurt Naber; F M E Wagenlehner
[Urinary tract infection - Case report].
Deutsche medizinische Wochenschrift (1946) 2001;126(40):1105.
2001: Werner W Hochreiter; Martin Ludwig; Wolfgang Weidner; F M E Wagenlehner; Kurt G Naber; Sonya Eremenco; B Arnold
[National Institutes of Health (NIH) Chronic Prostatitis Symptom Index. The German version].
Der Urologe. Ausg. A 2001;40(1):16-7.
2001: F M E Wagenlehner; Kurt G Naber
Uncomplicated urinary tract infections in women.
Current opinion in urology 2001;11(1):49-53.